FDA

Scholars debate ways to improve FDA’s accelerated approval mechanism.

Scholars argue that data-sharing lessons from clinical trials can apply to social media.

Scholar calls for regulators to correct the dangers of inadequate cosmetics regulations for women of color.

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

The Loper Bright decision leaves hundreds of pivotal health care regulations subject to litigation.

Scholar calls for Congress to empower regulators to limit exposure to cancer-causing chemicals.

FDA approves first over-the-counter continuous glucose monitor for U.S. patients.

Contaminated agricultural water is a well-known root cause of foodborne illness that regulators have struggled to address.

FDA proposes a rule that would prohibit the use of a toxic food additive in sodas.

Scholars assess the state of food-additive regulation.

Researchers address the challenges regulators face in protecting the public amid the rapid growth of neurotechnologies.

Scholars and practitioners debate whether and how to regulate off-label drug use.